drugset / Trial / NCT01044758

Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)

NCT01044758

RandomizedCrossoverDouble-blindBasic science

Summary

This research is being done to find out if daily use of the drug levetiracetam can improve memory function in individuals with memory problems like those associated with Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD).

Timeline

Start
2009-12
Primary completion
2012-07
Completion
2012-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Levetiracetam Other / unclassified 62.5 mg
Subject Levetiracetam Other / unclassified 125 mg
Subject Levetiracetam Other / unclassified 250 mg

Indications